DocGo Q4 Revenue at $74.9M, Exceeds Expectations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 16 2026
0mins
Should l Buy DCGO?
Reports Q4 revenue $74.9M, consensus $70.4M. Lee Bienstock, Chief Executive Officer of DocGo, commented "While 2025 was a year of transition and focus on our core business lines, the robust growth in our 'healthcare at any address' business - which includes care in the home, remote patient monitoring, mobile phlebotomy and virtual care services - supports our belief that DocGo's offering is well positioned to meet the needs of the evolving healthcare landscape." Bienstock continued "We are increasing guidance based on the record volumes we've seen thus far in 2026, and the anticipated full-year impact of our cost efficiency initiatives. We believe that our plan and resources are sufficient to enable the Company to achieve profitability in the second half of 2026."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy DCGO?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on DCGO
Wall Street analysts forecast DCGO stock price to rise
4 Analyst Rating
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.649
Low
1.50
Averages
3.13
High
4.00
Current: 0.649
Low
1.50
Averages
3.13
High
4.00
About DCGO
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
DocGo (DCGO) Q4 2025 Earnings Call Transcript
See More
DocGo Q4 Earnings Report Analysis
- Disappointing Earnings: DocGo reported a Q4 GAAP EPS of -$1.37, missing estimates by $1.23, indicating a significant decline in profitability that could negatively impact investor confidence.
- Revenue Performance: The total revenue for Q4 was $74.9 million, beating expectations by $4.54 million, although overall performance still lags behind last year, reflecting growth potential in specific business areas.
- Widening Net Loss: The net loss for Q4 reached $142.3 million, a substantial increase from $7.6 million in the same quarter last year, primarily due to $78 million in non-cash items, highlighting challenges in asset management.
- Cash Flow Situation: As of December 31, 2025, the company held approximately $68.3 million in cash and cash equivalents, a significant drop from $95.2 million as of September 30, 2025, reflecting liquidity pressure from the acquisition of SteadyMD and related transaction payments.
See More
DocGo to Release Q4 and Full Year 2025 Financial Results on March 16, 2025
- Earnings Release Schedule: DocGo will announce its fourth quarter and full year financial results for the period ending December 31, 2025, after market close on March 16, 2025, highlighting the company's performance in medical transportation and mobile health services.
- Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial results and outlook for 2026, which is expected to attract investor and analyst attention, enhancing the company's transparency.
- Innovative Healthcare Platform: DocGo's technology-enabled medical transportation and mobile health services aim to reshape the traditional healthcare system by providing high-quality, accessible care that enhances patient experience and strengthens market competitiveness.
- Telehealth Integration: DocGo's mobile health services facilitate patient treatment in collaboration with remote physicians, enabling care in the comfort of patients' homes or workplaces, and seamlessly bridging physical and virtual care through its medical transport services, thereby improving overall healthcare efficiency.
See More
DocGo to Release Q4 and Full Year 2025 Financial Results and Host Conference Call
- Earnings Release Schedule: DocGo will announce its financial results for Q4 and the full year 2025 after market close on March 16, 2025, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss financial results and outlook for 2026, which is expected to attract investor interest and bolster market confidence.
- Tech-Enabled Healthcare Services: DocGo is reshaping the traditional healthcare system through its innovative medical transportation and mobile health services platform, providing high-quality and accessible care to meet patients' immediate needs.
- Investor Relations Platform: The company's website offers a webcast of the conference call, enhancing interaction with investors and further improving the company's transparency and trustworthiness in the healthcare sector.
See More
DocGo CEO to Attend Health Conference
- Conference Participation: DocGo's CEO Lee Bienstock will participate in 1x1 meetings at the TD Cowen 46th Annual Health Care Conference on March 2, showcasing the company's leadership in mobile health services.
- Presentation Schedule: Bienstock is set to deliver a presentation at 9:10 AM ET on the same day, expected to highlight DocGo's innovative care delivery platform and its impact on the healthcare industry.
- Webcast Availability: The event will be webcasted on DocGo's investor relations website, ensuring that investors and the public can access real-time updates on the company's latest developments.
- Innovative Business Model: DocGo is reshaping the traditional healthcare system through services like mobile health, remote patient monitoring, and a virtual care network, enhancing patient care quality and increasing accessibility to healthcare services.
See More
Halper Sadeh Investigates DocGo Inc. Officers for Potential Fiduciary Breaches
- Legal Investigation Initiated: Halper Sadeh LLC is investigating whether certain officers of DocGo Inc. breached their fiduciary duties to shareholders, potentially leading to corporate governance reforms and the return of funds to the company.
- Shareholder Rights Protection: Long-term shareholders of DocGo may seek court-approved financial incentive awards, aimed at enhancing the company's transparency and accountability, thereby increasing shareholder value.
- Legal Fee Arrangement: The firm will handle the action on a contingent fee basis, meaning shareholders will not be responsible for out-of-pocket legal fees, reducing the financial burden of participation.
- Global Investor Support: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having previously recovered millions for defrauded investors, showcasing its expertise in protecting investor rights.
See More
DocGo (DCGO) Q4 2025 Earnings Call Transcript
See More
DocGo Q4 Earnings Report Analysis
- Disappointing Earnings: DocGo reported a Q4 GAAP EPS of -$1.37, missing estimates by $1.23, indicating a significant decline in profitability that could negatively impact investor confidence.
- Revenue Performance: The total revenue for Q4 was $74.9 million, beating expectations by $4.54 million, although overall performance still lags behind last year, reflecting growth potential in specific business areas.
- Widening Net Loss: The net loss for Q4 reached $142.3 million, a substantial increase from $7.6 million in the same quarter last year, primarily due to $78 million in non-cash items, highlighting challenges in asset management.
- Cash Flow Situation: As of December 31, 2025, the company held approximately $68.3 million in cash and cash equivalents, a significant drop from $95.2 million as of September 30, 2025, reflecting liquidity pressure from the acquisition of SteadyMD and related transaction payments.
See More
DocGo to Release Q4 and Full Year 2025 Financial Results on March 16, 2025
- Earnings Release Schedule: DocGo will announce its fourth quarter and full year financial results for the period ending December 31, 2025, after market close on March 16, 2025, highlighting the company's performance in medical transportation and mobile health services.
- Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss the financial results and outlook for 2026, which is expected to attract investor and analyst attention, enhancing the company's transparency.
- Innovative Healthcare Platform: DocGo's technology-enabled medical transportation and mobile health services aim to reshape the traditional healthcare system by providing high-quality, accessible care that enhances patient experience and strengthens market competitiveness.
- Telehealth Integration: DocGo's mobile health services facilitate patient treatment in collaboration with remote physicians, enabling care in the comfort of patients' homes or workplaces, and seamlessly bridging physical and virtual care through its medical transport services, thereby improving overall healthcare efficiency.
See More
DocGo to Release Q4 and Full Year 2025 Financial Results and Host Conference Call
- Earnings Release Schedule: DocGo will announce its financial results for Q4 and the full year 2025 after market close on March 16, 2025, reflecting the company's commitment to transparency and investor communication.
- Conference Call Details: Management will host a conference call at 5:00 p.m. ET on the same day to discuss financial results and outlook for 2026, which is expected to attract investor interest and bolster market confidence.
- Tech-Enabled Healthcare Services: DocGo is reshaping the traditional healthcare system through its innovative medical transportation and mobile health services platform, providing high-quality and accessible care to meet patients' immediate needs.
- Investor Relations Platform: The company's website offers a webcast of the conference call, enhancing interaction with investors and further improving the company's transparency and trustworthiness in the healthcare sector.
See More
DocGo CEO to Attend Health Conference
- Conference Participation: DocGo's CEO Lee Bienstock will participate in 1x1 meetings at the TD Cowen 46th Annual Health Care Conference on March 2, showcasing the company's leadership in mobile health services.
- Presentation Schedule: Bienstock is set to deliver a presentation at 9:10 AM ET on the same day, expected to highlight DocGo's innovative care delivery platform and its impact on the healthcare industry.
- Webcast Availability: The event will be webcasted on DocGo's investor relations website, ensuring that investors and the public can access real-time updates on the company's latest developments.
- Innovative Business Model: DocGo is reshaping the traditional healthcare system through services like mobile health, remote patient monitoring, and a virtual care network, enhancing patient care quality and increasing accessibility to healthcare services.
See More
Halper Sadeh Investigates DocGo Inc. Officers for Potential Fiduciary Breaches
- Legal Investigation Initiated: Halper Sadeh LLC is investigating whether certain officers of DocGo Inc. breached their fiduciary duties to shareholders, potentially leading to corporate governance reforms and the return of funds to the company.
- Shareholder Rights Protection: Long-term shareholders of DocGo may seek court-approved financial incentive awards, aimed at enhancing the company's transparency and accountability, thereby increasing shareholder value.
- Legal Fee Arrangement: The firm will handle the action on a contingent fee basis, meaning shareholders will not be responsible for out-of-pocket legal fees, reducing the financial burden of participation.
- Global Investor Support: Halper Sadeh LLC represents investors worldwide, focusing on combating securities fraud and corporate misconduct, having previously recovered millions for defrauded investors, showcasing its expertise in protecting investor rights.
See More
